Johnson & Johnson, AbbVie, Teva and Endo to face pharma’s first opioid trial since 2019

Johnson & Johnson, AbbVie, Teva and Endo to face pharma’s first opioid trial since 2019
esagonowsky
Mon, 04/19/2021 – 09:30